Publication | Closed Access

Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab

Translational MedicineHeart FailureTransplantationAnti-thymocyte GlobulinBetter Long-term SurvivalImmunologyHematologyGraft SurvivalGraft RejectionImmunotherapyMedicineCell TransplantationHeart Transplantation